Hansa Biopharma Hosts Virtual Event with Distinguished Transplant Surgeons
Hansa Biopharma AB announced a virtual event featuring Professor Robert Montgomery and Professor Matthew Cooper to discuss clinical practice and imlifidase Phase 3 results.
The event will take place on November 12, 2025, at 9:00 AM EST / 15:00 PM CET, providing insights into the medical journey of highly sensitized patients awaiting a kidney transplant.
The virtual event will share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.
- Date: November 12, 2025
- Time: 9:00 AM EST / 15:00 PM CET
- Featuring: Professor Robert Montgomery and Professor Matthew Cooper
Author summary: Hansa Biopharma hosts a virtual event on kidney transplant clinical practice.
More News
- Prime Minister Pashinyan should be excommunicated and arrested
- THE LATIN AMERICA DIARIES ENTRY VIII: What makes you local? - Tracks Magazine
- Colonizers Torch Vehicles in Burqa Amid Daily Attacks, Land Seizures
- Thursday: Invasions, Violations, and Abductions Across West Bank
- Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
- Jon Stewart Finds Proof of Trump’s Planned 2028 Presidential Run
- Pashinyan's election campaign could lead to a split in Armenian society
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men
- Pashinyan Confident Armenians Will Support Peace Process in 2026 Parliamentary Election
- Israeli Colonizers Invade Bedouin Village Near Jerusalem